<!DOCTYPE html>
<html lang="en">
<head>
<?php $id='865-957'; include '../../seo.php';?>
<?php include '../../side-nav.php';?>
<div class="page-content">
<!--section-->
<div class="section mt-0">
<div class="breadcrumbs-wrap">
<div class="container">
<div class="breadcrumbs">
<a href="https://sprintdiagnostics.in/">Home</a>
<a href="https://www.sprintdiagnostics.in/hyderabad/test/">Test</a>
<span>FISH for BCR/ABL - t(9;22) </span>
</div>
</div>
</div>
</div>
<!--//section-->
<!--section-->
<div class="section page-content-first">
<div class="container mt-6">
<div class="row">
<div class="col-md-8 col-lg-8 mt-0 mt-md-0 mb-4">
<h1 class="test-h1">FISH for BCR/ABL - t(9;22) </h1>
<div class="post-text">
<p>The FISH (Fluorescence In Situ Hybridization) test for BCR/ABL t(9;22) is an essential diagnostic and
monitoring tool in cases of chronic myeloid leukemia (CML) and certain types of acute lymphoblastic
leukemia (ALL). The translocation t(9;22), often termed the Philadelphia chromosome, involves a swap
of genetic material between chromosomes 9 and 22, resulting in the fusion of the BCR and ABL genes.
The BCR/ABL fusion gene leads to the production of an abnormal tyrosine kinase protein, which
contributes to uncontrolled cell growth and division - characteristic features of leukemia.
 </p>
<p> The FISH test for BCR/ABL utilizes fluorescent probes that bind to specific areas within the DNA,
including the BCR and ABL genes. This allows the visualization of the chromosomal translocation under a
fluorescence microscope, aiding in the detection and monitoring of diseases related to this gene fusion.</p>
<div class="table-wrap">
<table class="table table-striped">
	<thead>
		<tr>
			<th scope="col">Test Name</th>
			<td scope="col">FISH for BCR/ABL - t(9;22) </td>
		</tr>
	</thead>
	<tbody>
		<tr>
			<th scope="row">Sample Type</th>
			<td>Blood or Bone Marrow</td>
		</tr>
		<tr>
			<th scope="row">Preparations Required</th>
			<td>There are no specific preparation instructions for patients before undergoing this
test. However, it is important to follow any instructions given by the doctor or laboratory. </td>
		</tr>
		<tr>
			<th scope="row">Report Time</th>
			<td>5 days</td>
		</tr>
		<tr>
			<th scope="row">Price in Hyderabad</th>
			<td>₹ 4000 </td>
		</tr>
	</tbody>
</table>
</div>
<div class="post-text">
<h2 class="test-h2 mt-3"> What is the FISH test for BCR/ABL t(9;22)?</h2>
	<p>The FISH test for BCR/ABL t(9;22) is a diagnostic procedure that detects the presence of the Philadelphia
chromosome, a genetic abnormality resulting from a translocation between chromosomes 9 and 22.
This translocation leads to the creation of the BCR/ABL fusion gene, associated with chronic myeloid
leukemia and some types of acute lymphoblastic leukemia.</p>

<h2 class="test-h2 mt-3"> Why is the FISH test for BCR/ABL t(9;22) important?</h2>
<p>The test is important for the diagnosis of CML and certain cases of ALL. It is also used for monitoring the
progression of these diseases and evaluating the effectiveness of therapies, especially tyrosine kinase
inhibitors.</p>
	<!--section achieved-->
	<?php include "../../include/iconsbox.php" ?>
	<!--//section achieved-->
	

<h2 class="test-h2 mt-3">How is the test performed?</h2>
<p>A blood sample or bone marrow aspirate is collected from the patient. The sample is then treated with
fluorescent probes that attach to the BCR and ABL genes. Under a fluorescence microscope, the
presence of the fusion gene can be visually confirmed if the probes are in close proximity.</p>

<h2 class="test-h2 mt-3"> What do the results mean?</h2>
<p>A positive result indicates the presence of the BCR/ABL fusion gene and may confirm a diagnosis of CML
or a type of ALL. A negative result suggests the absence of the gene fusion. In patients undergoing
treatment, a decrease in the fusion gene may indicate a positive response to therapy.</p>

<h2 class="test-h2 mt-3"> Who should undergo this test?</h2>
<p>This test is recommended for individuals suspected of having CML or ALL, and for patients already
diagnosed with these conditions to monitor disease progression and response to treatment.</p>

<h2 class="test-h2 mt-3">Are there any risks associated with this test?</h2>
<p>The risks are minimal and primarily relate to the blood or bone marrow sample collection. There might
be slight pain, bleeding, or bruising at the collection site.</p>

<h2 class="test-h2 mt-3"> How does the BCR/ABL fusion gene contribute to leukemia?</h2>
<p>The BCR/ABL fusion gene produces an abnormal tyrosine kinase protein that promotes uncontrolled cell
division and growth, leading to the overproduction of white blood cells, a characteristic of leukemia.</p>

<h2 class="test-h2 mt-3">Are there treatments available for leukemia caused by the BCR/ABL fusion gene?</h2>
<p>Yes, tyrosine kinase inhibitors such as imatinib are effective treatments for leukemia caused by the
BCR/ABL fusion gene. These drugs inhibit the action of the abnormal protein produced by the fusion
gene.</p>
<h2 class="test-h2 mt-3">How often should this test be performed?</h2>
<p>For patients under treatment for CML or ALL, the frequency of testing should be determined by the
doctor based on the patient's response to treatment and disease progression. For newly diagnosed
patients, the test is usually performed at the time of diagnosis.</p>

<h2 class="test-h2 mt-3">Can this test be used to detect other chromosomal abnormalities?</h2>
<p>No, this specific test is designed to detect the t(9;22) translocation. There are other FISH tests available
for different chromosomal abnormalities.</p>

<h2 class="test-h2 mt-3"> What should I do if I test positive for the BCR/ABL fusion gene?</h2>
<p> If you test positive, it's important to consult your doctor to discuss treatment options and next steps in managing the disease.</p>

<h2 class="test-h2 mt-3">Can environmental factors affect the results of this test?</h2>
<p>The results of the FISH test for BCR/ABL are not influenced by environmental factors, but it is crucial
that the test is performed in a specialized laboratory to ensure accuracy.</p>

<h2 class="test-h2 mt-3"> What are the options if a patient doesn’t respond to tyrosine kinase inhibitors?</h2>
<p>If a patient does not respond to tyrosine kinase inhibitors, alternative therapies including different
medication regimens, stem cell transplant, or participation in clinical trials may be considered.</p>

<h2 class="test-h2 mt-3"> Can a person inherit the BCR/ABL fusion gene?</h2>
<p>The BCR/ABL fusion gene is not inherited; it is acquired during a person's lifetime. The cause of the
translocation is not fully understood, but it is not passed down from parents to children.</p>

<h2 class="test-h2 mt-3"> Is there a cure for CML or ALL with BCR/ABL fusion gene?</h2>
<p>While CML and ALL are not always curable, they can often be effectively managed with treatment. Early
detection and appropriate treatment are essential for improving prognosis.</p>

<p>The role of the BCR/ABL fusion gene in leukemia is crucial for diagnosis, monitoring, and management of
the disease. The FISH test for BCR/ABL t(9;22) is an indispensable tool that enables doctors to make
informed decisions regarding the best treatment strategies for patients. Open communication with your
doctor is vital in understanding the implications of test results and exploring the available options for
disease management and therapy.</p>

	
</div>		
</div>			
</div>
<!--form section-->
<?php include "../../include/bookslot.php" ?>
<!--form section-->
</div>
</div>
<!--//section-->
</div>
</div>
<?php include '../../footer.php';?>
</body>
</html>